233 related articles for article (PubMed ID: 17916779)
1. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload.
Yoshioka J; Imahashi K; Gabel SA; Chutkow WA; Burds AA; Gannon J; Schulze PC; MacGillivray C; London RE; Murphy E; Lee RT
Circ Res; 2007 Dec; 101(12):1328-38. PubMed ID: 17916779
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity.
Yoshioka J; Schulze PC; Cupesi M; Sylvan JD; MacGillivray C; Gannon J; Huang H; Lee RT
Circulation; 2004 Jun; 109(21):2581-6. PubMed ID: 15123525
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-interacting protein suppresses bladder carcinogenesis.
Nishizawa K; Nishiyama H; Matsui Y; Kobayashi T; Saito R; Kotani H; Masutani H; Oishi S; Toda Y; Fujii N; Yodoi J; Ogawa O
Carcinogenesis; 2011 Oct; 32(10):1459-66. PubMed ID: 21771725
[TBL] [Abstract][Full Text] [Related]
4. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.
Nishida K; Yamaguchi O; Hirotani S; Hikoso S; Higuchi Y; Watanabe T; Takeda T; Osuka S; Morita T; Kondoh G; Uno Y; Kashiwase K; Taniike M; Nakai A; Matsumura Y; Miyazaki J; Sudo T; Hongo K; Kusakari Y; Kurihara S; Chien KR; Takeda J; Hori M; Otsu K
Mol Cell Biol; 2004 Dec; 24(24):10611-20. PubMed ID: 15572667
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus.
van Greevenbroek MM; Vermeulen VM; Feskens EJ; Evelo CT; Kruijshoop M; Hoebee B; van der Kallen CJ; de Bruin TW
Diabet Med; 2007 May; 24(5):498-504. PubMed ID: 17381501
[TBL] [Abstract][Full Text] [Related]
6. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-specific Txnip C247S mutation improves left ventricular functional reserve in streptozotocin-induced diabetic mice.
Mukai N; Nakayama Y; Abdali SA; Yoshioka J
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H259-H274. PubMed ID: 34085839
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.
Wang Z; Rong YP; Malone MH; Davis MC; Zhong F; Distelhorst CW
Oncogene; 2006 Mar; 25(13):1903-13. PubMed ID: 16301999
[TBL] [Abstract][Full Text] [Related]
9. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity.
Schulze PC; Liu H; Choe E; Yoshioka J; Shalev A; Bloch KD; Lee RT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2666-72. PubMed ID: 17023680
[TBL] [Abstract][Full Text] [Related]
11. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
[TBL] [Abstract][Full Text] [Related]
12. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
Hamada Y; Fukagawa M
Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells.
Pang ST; Hsieh WC; Chuang CK; Chao CH; Weng WH; Juang HH
J Mol Endocrinol; 2009 Mar; 42(3):205-14. PubMed ID: 19052253
[TBL] [Abstract][Full Text] [Related]
14. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
[TBL] [Abstract][Full Text] [Related]
15. Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells.
Müller P; Kazakov A; Semenov A; Böhm M; Laufs U
Cardiovasc Res; 2008 Jan; 77(1):151-9. PubMed ID: 18006457
[TBL] [Abstract][Full Text] [Related]
16. The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients.
Erkeland SJ; Palande KK; Valkhof M; Gits J; Danen-van Oorschot A; Touw IP
Leuk Res; 2009 Oct; 33(10):1367-71. PubMed ID: 19327827
[TBL] [Abstract][Full Text] [Related]
17. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
[TBL] [Abstract][Full Text] [Related]
18. Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury.
Yoshioka J; Chutkow WA; Lee S; Kim JB; Yan J; Tian R; Lindsey ML; Feener EP; Seidman CE; Seidman JG; Lee RT
J Clin Invest; 2012 Jan; 122(1):267-79. PubMed ID: 22201682
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells.
Cheng GC; Schulze PC; Lee RT; Sylvan J; Zetter BR; Huang H
Exp Cell Res; 2004 Nov; 300(2):297-307. PubMed ID: 15474995
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.
Oka T; Maillet M; Watt AJ; Schwartz RJ; Aronow BJ; Duncan SA; Molkentin JD
Circ Res; 2006 Mar; 98(6):837-45. PubMed ID: 16514068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
